NSPR
InspireMD, Inc.Company with tickers: NSPR
CIK
1433607
CUSIP
45779A846
Shares Outstanding
46,838,962
13F Activity (30d)
25 filings
25 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $3,398,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | $687,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | $14,665,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $4,763,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-13,978,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-13,689,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.16 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.16 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |